|
|
Article: Watson Pharmaceuticals Launches Terconazole Vaginal Cream 0.8%.
- Article from:
- PR Newswire
- Article date:
- April 8, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that it has initiated shipments of terconazole in a 3-day cream. Terconazole vaginal cream 0.8% is the equivalent of Terazol(R) 3 (terconazole) vaginal cream 0.8%, and is indicated for the local treatment of vulvovaginal candidiasis. For the 12-months ending February 2004, Terazol(R) 3 vaginal cream 0.8% had sales of approximately $27.7 million, according to IMS Health data.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells ...